Non-technical summary Specific membrane proteins called 'M channels' control the excitability of peripheral pain-sensing nerves. In certain disease conditions (e.g. inflammation), M channels become inhibited, and this contributes to the increased excitability of these nerves and, ultimately, to pain sensation. Recently, chemical compounds that enhance M channel activity have been discovered and were suggested as prospective analgesics. However, it was previously unknown whether these M channel enhancers could augment the activity of M channels that are inhibited in inflammatory conditions. We tested four compounds that possess M channel enhancer activity in various conditions mimicking inflammation. Our conclusions suggest that while the overall effect of the enhancers is reduced when M channels are inhibited, the remaining enhancement is sufficient to 'recover' M channel activity from inflammation-induced inhibition. Our results support pharmacological targeting of M channels in peripheral nerves as a strategy against inflammatory pain.Abstract M-type (Kv7, KCNQ) K + channels control the resting membrane potential of many neurons, including peripheral nociceptive sensory neurons. Several M channel enhancers were suggested as prospective analgesics, and targeting M channels specifically in peripheral nociceptors is a plausible strategy for peripheral analgesia. However, receptor-induced inhibition of M channels in nociceptors is often observed in inflammation and may contribute to inflammatory pain. Such inhibition is predominantly mediated by phospholipase C. We investigated four M channel enhancers (retigabine, flupirtine, zinc pyrithione and H 2 O 2 ) for their ability to overcome M channel inhibition via two phospholipase C-mediated mechanisms, namely depletion of membrane phosphatidylinositol 4,5-bisphosphate (PIP 2 ) and a rise in intracellular Ca 2+ (an action mediated by calmodulin). Data from overexpressed Kv7.2/Kv7.3 heteromers and native M currents in dorsal root ganglion neurons suggest the following conclusions. (i) All enhancers had a dual effect on M channel activity, a negative shift in voltage dependence and an increase of the maximal current at saturating voltages. The enhancers differed in their efficacy to produce these effects. (ii) Both PIP 2 depletion and Ca 2+ /calmodulin strongly reduced the M current amplitude; however, at voltages near the threshold for M channel activation (−60 mV) all enhancers were able to restore M channel activity to a control level or above, while at saturating voltages the effects were more variable. (iii) Receptor-mediated inhibition of M current in nociceptive dorsal root ganglion neurons did not reduce the efficacy of retigabine or flupirtine to hyperpolarize the resting membrane potential. In conclusion, we show that all four M channel enhancers tested could overcome both PIP 2 and Ca 2+ -calmodulin-induced inhibition of Kv7.2/7.3 at voltages close to the threshold for action potential firing (−60 mV) but generally had reduced efficacy at a saturating voltag...